Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject having given her/his informed, written consent.~  * Subject cooperative and aware of the modalities of use and the necessity and duration of the controls so that perfect adhesion to the protocol can be expected.~ * Subject being psychologically able to understand information and to give their/his/her consent.~ * Age: more than 18 years.~ * Subject with superficial onychomycosis on at least one great toenail or light to moderate disto-lateral onychomycosis (without matrix involvement and involvement \<2/3 of the tablet).~ * Subject with positive KOH staining.~ * Subject having stopped any systemic antifungal treatment since at least 6 months before inclusion and/or any topical antifungal treatment since at least 3 months before inclusion.~ * Female subjects of childbearing potential should use an accepted contraceptive regimen since at least 12 weeks before the beginning of the study, during all the study and at least 1 month after study end.~Exclusion Criteria:~* Subject considered by the Investigator likely to be non-compliant with the protocol.~* Patient enrolled in another clinical trial during the test period.~  · Woman being pregnant, nursing or planning a pregnancy during the course of this study.~* Subject having a known allergy to one of the constituents of the tested products.~* Patient suffering from serious or progressive diseases (to investigator's discretion) such as uncontrolled diabetes, peripheral circulatory disease, HIV, psoriasis, lichen planus, immunosuppressive pathology...~* Subject with cutaneous pathology on studied zone (other than onychomycosis like angioma, dermatitis...).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Excilor Forte (Type: EXPERIMENTAL): One application of the MD daily (at same time point), preferably after showering/bathing, during the complete study period.
- Loceryl 5% (Type: ACTIVE_COMPARATOR): One application per week of the positive control Loceryl 5% during the whole study period.

Based on this trial design, predict the completion outcome and termination type (if applicable).